Katherine Prendergast, MD

Specialty: Surgical Oncology
Department of Surgical Oncology

Research Interests:

  • Hepato-pancreaticobiliary malignancies
  • Gastric cancer
  • Sarcoma
  • Surgical education

Biography

I am one of the complex general surgical oncology fellows at Roswell Park Comprehensive Cancer Center. I received my BS in Biology at Duke University and my MD at Vanderbilt University Medical Center. 

I completed my General Surgery residency at NYU Langone. During that time, I also completed a two-year research fellowship at Memorial Sloan Kettering Cancer Center. My clinic interests include gastric cancer, hepato-pancreaticobiliary malignancies, and sarcoma.

Positions

Roswell Park Comprehensive Cancer Center

  • Surgical Oncology Fellow
  • Department of Surgical Oncology

Background

Education and Training

  • 2015-2019 - MD - Vanderbilt University Medical Center, Nashville, TN

Residency

  • 2019-2026 - General Surgery, NYU Langone Medical Center, New York, NY

Fellowship

  • 2021-2023 - Surgical Research Fellowship - Memorial Sloan Kettering Cancer Center, New York, NY
  • 2026-2028 - Complex General Surgical Oncology Fellowship - Roswell Park Comprehensive Cancer Center, Buffalo, NY

Professional Memberships

  • Society of Surgical Oncology
  • American College of Surgeons

Honors & Awards

  • 2025-2026 - Academic Chief Resident, NYU Langone General Surgery Residency
  • 2021-2023 - Gorin Research Fellowship, Memorial Sloan Kettering Cancer Center
  • 2015-2019 - Jack Martin Scholarship, Vanderbilt University Medical Center
  • 2015 - Phi Beta Kappa, Duke University

Research Overview

  • Prendergast KM and Crago AM. “Multi-disciplinary management of retroperitoneal sarcomas.” Current Surgery Reports. 2024 September. 12:417-424.
  • Hu J, Hameed MR, Agaram NP, Whiting KA, Qin L, Villano AM, O’Connor RB, Rozenberg JM, Cohen S, Prendergast K, Kryeziu S, White RL, Posner MC, Socci ND, Gounder MM, Singer S, Crago AM. “PDGFRB signaling cooperates with beta-catenin to modulate c-Abl and biologic behavior of desmoid-type fibromatosis.” Clinical Cancer Research. 2024 January. 30(2):450-462.
  • Prendergast K, Kryeziu S, Crago A. “The evolving management of desmoid fibromatosis”. The surgical clinics of North America. 2022 August. 102(4); 667-677.
  • Kaslow SR*, Prendergast KM*, Vitiello GA, Hani L, Berman RS, Lee AY, Correa-Gallego C. “Systemic therapy for duodenal adenocarcinoma: an analysis of the National Cancer Center Database (NCDB).” Surgery. 2022 July. 172(1):358-364.
  • Prendergast KM, Marincola Smith P, Kiernan CM, Tran TB, Postlewait LM, Maithel SK, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Shirley, L, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Votanopoulos KI, Levine EA, Poultsides GA, Solórzano CC. “Features of synchronous versus metachronous metastasectomy for adrenal cortical carcinoma.” Surgery. 2020 February. 167(2):352-357.